IP Library Granted Patent US 10,980,469
Granted Patent B2
US 10,980,469 · App. 15/766,690 · Granted Apr 20, 2021

Method and apparatus for detecting and classifying seizure activity

Inventors: Michael R. Girouard (Shavano Park, TX); Luke E. Whitmire (San Antonio, TX); Jose E. Cavazos (San Antonio, TX)
Assignee: Brain Sentinel, Inc.
A61B5/4094A61B5/0488A61B5/726A61B5/7267A61B5/0015
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,980,469
App. No.
15/766,690
Granted
Apr 20, 2021
Kind
B2
Abstract

A method of monitoring a patient for seizure activity may include monitoring the patient by collecting an electromyography signal, determining features of the signal using wavelet analysis and inputting determined feature values into a neural network trained to detect seizure activity. Related apparatuses are also described.

Claims (32)

1. A method of monitoring a patient for seizure activity comprising:

monitoring a patient using one or more electromyography electrodes to obtain an electromyography signal during a monitoring period;

processing with a processor said electromyography signal to determine values of one or more features of said electromyography signal;

inputting said values of the one or more features of said electromyography signal into a neural network trained to identify an increased risk of central nervous system depression during recovery from a detected seizure;

said neural network being trained to identify said increased risk of central nervous system depression during recovery from said seizure based on levels of oxygen saturation as measured during one or more training periods;

processing said values of the one or more features of said electromyography signal using the neural network to determine one or more outputs of one or more output nodes of the neural network, wherein said one or more outputs include a first output indicating an increased risk of central nervous system depression during recovery from said seizure; and

initiating a response based on said detected seizure.

2. The method of claim 1 wherein at least one output among the one or more outputs indicates an identification of clonic phase seizure activity.

3. The method of claim 1 wherein at least one output among the one or more outputs indicates an identification of tonic phase seizure activity.

4. The method of claim 1 wherein at least one output among the one or more outputs indicates detection of an electromyography signal pattern that is indicative of normal recovery from a seizure.

5. The method of claim 4 said neural network being trained to detect normal recovery from a seizure based on a correlation between said electromyography signal pattern and normal oxygen saturation level measured for one or more patients during the one or more training periods.

6. The method of claim 1 wherein at least one output among the one or more outputs is a prediction of a value of a physiological parameter that may be experienced by the patient following some time delay.

7. The method of claim 6 wherein said physiological parameter is oxygen saturation.

8. The method of claim 1 further comprising monitoring the patient using one or more saturated oxygen sensors during said monitoring period.

9. The method of claim 1 wherein said increased risk of central nervous system depression during recovery from said seizure is associated with a level of oxygen saturation of less than 80% to 90%.

10. The method of claim 1 wherein at least one output among the one or more outputs indicates an identification of a non-epileptic psychogenic seizure.

11. The method of claim 1 wherein said processing includes decomposition of the electromyography signal using a wavelet transform.

12. The method of claim 1 wherein said one or more of features of said electromyography signal are appropriate to identify changes in clonic-phase burst activity.

13. The method of claim 1 wherein said one or more of features of said electromyography signal include a clonic-phase burst repetition rate or clonic-phase burst amplitude.

14. An apparatus for monitoring a patient for seizure activity comprising:

one or more electromyography electrodes configured to provide an electromyography signal of seizure-related muscle activity of a patient during a patient monitoring period;

a processor configured to receive the electromyography signal and process the electromyography signal to determine values of one or more features of said electromyography signal;

said processor further configured to input said values of the one or more features of said electromyography signal into a neural network trained to identify increased risk of central nervous system depression related to a detected seizure;

said neural network being trained to identify said increased risk of central nervous system depression during recovery from said seizure based on levels of oxygen saturation as measured during one or more training periods;

said processor further configured to process said values of the one or more features of said electromyography signal using the neural network to determine one or more outputs of one or more output nodes of the neural network, wherein said one or more outputs include a first output indicating detection of an increased risk of central nervous system depression during recovery from said seizure; and

said processor further configured to initiate a response based on said detected seizure.

15. The apparatus of claim 14 wherein at least one output among the one or more outputs indicates an identification of clonic phase seizure activity.

16. The apparatus of claim 14 wherein at least one output among the one or more outputs indicates identification of tonic phase seizure activity.

17. The apparatus of claim 14 further comprising a sensor suitable for measuring saturated oxygen levels for said patient.

18. The apparatus of claim 14 wherein at least one output among the one or more outputs indicates an identification of anon-epileptic psychogenic seizure.

19. The apparatus of claim 14 wherein said increased risk of central nervous system depression during recovery from said seizure is associated with a level of oxygen saturation of less than 80% to 90%.

20. The apparatus of claim 14 wherein at least one output among the one or more outputs indicates detection of an electromyography signal pattern that is indicative of normal recovery from a seizure.

Assignments (4)
SECURITY INTEREST Recorded Aug 8, 2022
From: NOVELA NEUROTECHNOLOGIES, INC.
To: HCV INVESTMENTS, LLC
Reel/Frame 060746/0143 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2022
From: HCV INVESTMENTS, LLC
To: NOVELA NEUROTECHNOLOGY
Reel/Frame 060065/0971 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2022
From: BRAIN SENTINEL, INC.
To: HCV INVESTMENTS, LLC
Reel/Frame 060043/0697 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2018
From: GIROUARD, MICHAEL R.; WHITMIRE, LUKE E.; CAVAZOS, JOSE E.
To: BRAIN SENTINEL, INC.
Reel/Frame 045465/0049 →
Continuity (2)
Provisional Application 62239161 · Oct 8, 2015
Related Publication 20180289310A1 · Oct 11, 2018
Cited By (5)
US 12,239,450 US 12,350,061 US 12,357,225 US 12,667,300 US 12,708,320